22%

Average annual turnover rate for hospital registered nurses in the United States. Source: NSI National Health Care Retention and RN Staffing Report.

Every time a trained clinical staff member leaves a facility, the device competency they carried leaves with them. The scrub tech who knew the rotator cuff repair system inside out. The circulating nurse who had run the spine fixation cases for three years. The OR coordinator who managed the instrument sets for six different manufacturers. When they walk out, the knowledge walks with them.

For facilities managing high device volumes across multiple surgical specialties, staff turnover creates a continuous retraining burden that falls on clinical educators, charge nurses, and surgical services directors who are already carrying full workloads. The distributor relationship is one of the most underused levers for managing that burden systematically.

The competency gap turnover creates

New clinical staff arrive with general training but rarely with product-specific competency for the devices already in use at a facility. The gap between what they know and what the OR requires is filled by on-the-job learning, which is inconsistent, time-consuming, and carries risk during the period before competency is established.

That gap is widest in the first three to six months of a new hire’s tenure, precisely when the pressure to be productive is highest. For facilities running lean surgical teams, one undertrained staff member on a complex case creates friction that affects the whole team.

How a strong distributor relationship reduces the burden

A distributor whose medical sales consultants provide structured, repeatable in-service training on every product in their portfolio gives facilities a reliable resource for closing competency gaps as they appear. When a trained scrub tech leaves and a new one joins, the in-service does not need to be rebuilt from scratch. The distributor delivers it.

Synchrocare’s medical sales consultants are trained to provide ongoing in-service support, technique guides, case studies, and FAQs across every product in the portfolio. That continuity means the training infrastructure does not depend on institutional memory that walks out the door when staff leave.

Documentation that supports compliance and accreditation

Beyond the operational benefit, documented device competency is a compliance and accreditation requirement. Facilities need to demonstrate that staff are trained on the devices they use, and that training is current. When turnover is high, keeping that documentation current is a significant administrative task.

A distributor whose in-service process is structured, consistent, and documentable supports the facility’s compliance posture directly. Synchrocare conducts all clinical support and training activities in full compliance with applicable regulations and industry standards, providing the kind of audit-ready engagement that facilities operating under accreditation scrutiny need from every vendor relationship.

Building resilience into your training infrastructure

The facilities that manage turnover most effectively are those that have built their device-training infrastructure around reliable external resources rather than on internal institutional knowledge alone. Technique guides posted in procedure rooms. FAQs available to all OR staff. A medical sales consultant who answers calls before cases rather than only after complications.

That resilience does not eliminate the cost of turnover. It reduces the clinical and operational impact of it, which is the most realistic goal for any administrator managing a high-volume surgical program.

To learn more about Synchrocare’s clinical support and training resources, visit www.synchrocare.com.

Day one as a Synchrocare franchise owner does not start in a hospital. It starts in training. That is by design. The decisions made in the first ninety days of any medical device sales territory determine the trajectory of the next three years, and those decisions are better when they are made from a foundation of clinical knowledge, product familiarity, and a clear market entry plan rather than the pressure to generate revenue immediately.

Here is what those first ninety days look like in practice.

Weeks one through four: the training program

The first weeks of your franchise are dedicated to Synchrocare’s comprehensive medical sales consultant training program. That program covers the full product portfolio across all our manufacturer partners, procedure-relevant anatomy for each product’s clinical application, surgical technique considerations, and the complete compliance framework, including the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act.

Background checks and insurance requirements are confirmed during this period. You do not enter any facility until training is complete. That standard is non-negotiable across the Synchrocare network, and it is the foundation of the clinical credibility you will carry into every surgeon relationship you build.

Weeks four through eight: territory orientation and first calls

With training complete, the focus shifts to territory orientation. This means mapping the surgical volume in your geography, identifying the facilities and specialties where Synchrocare’s portfolio has the strongest clinical fit, and prioritising the first calls based on that analysis rather than convenience or existing personal relationships.

The first calls in a new territory are not about closing business. They are about establishing credibility, understanding the clinical environment, and identifying where your portfolio addresses a genuine unmet need. Franchise owners who approach this phase with patience and preparation build relationships that generate consistent, long-term value. Those who rush to the revenue conversation find it difficult to recover the trust they bypassed.

Weeks eight through twelve: first cases and clinical support

By weeks eight through twelve, the goal is first cases. These are the moments where the training becomes visible. A franchise owner who walks into the OR prepared, answers clinical questions confidently, and provides the kind of case support that makes a surgeon’s experience with a new device positive is building the territory that will sustain their business for years.

Synchrocare’s back-office infrastructure, customer service support, and clinical resources are available from day one of market entry. Technique guides, case study materials, product brochures, and access to Synchrocare’s clinical team mean franchise owners are never navigating a difficult case question alone. The network is the support structure. The franchise owner is the clinical relationship.

Ninety days in, a Synchrocare franchise owner has a clear picture of their territory, a set of established surgeon relationships, their first cases on record, and a business that is beginning to build the equity that comes from work done right from the start.

To learn more about the Synchrocare franchise opportunity, visit www.synchrocare.com/franchising.

Rotator cuff surgery has a problem that surgical technique alone has not solved. The failure rate for rotator cuff repair has been reported to be between 20% and over 90%, depending on tear size, patient age, and tissue quality. The most common reason for that failure is structural failure at the surgical site, specifically the inability of the repaired tissue to hold its position while biologic healing progresses. Synthasome was founded in 2003 to address that problem from a materials science perspective.

Synthasome is an advanced orthobiologics company dedicated to the creation of products that aid in soft tissue repair, regeneration, and replacement. Founded by a team of bioengineers and orthopedic specialists with a shared objective of using tissue engineering and functional bioengineering to address unmet clinical needs in orthopaedic and musculoskeletal applications, Synthasome has developed its first FDA 510(k) cleared product, X-Repair, through a series of federally funded research projects. Synchrocare distributes Synthasome products as part of its national specialty medical device portfolio.

What X-Repair is and how it works

X-Repair is a proprietary and patented surgical mesh fabricated from poly-L-lactic acid, a slowly degradable synthetic polymer with an established safety record across many clinical and implantable device applications. The mesh is woven to produce high tensile stiffness and strength, with mechanical properties specifically designed to be similar to native human tendon. That similarity is the foundation of how X-Repair works.

When sutured over torn or degenerative tissue as reinforcement, X-Repair defrays the load placed on the sutures and acts as a scaffold for tissue that is too fragile to maintain a strong connection to bone. The implant is biocompatible and allows rapid tissue ingrowth throughout the mesh structure. It degrades slowly over 12 to 24 months, maintaining approximately 90% of its strength at 12 months. That slow degradation rate is deliberate: it allows biologic repair to proceed and establish stability before the mechanical support of X-Repair diminishes. Because X-Repair degrades in the body, surgical removal is not required.

X-Repair is stiffer and stronger than other augmentation products, with mechanical properties equivalent to human tendon and high suture retention strength that allows those properties to be fully imposed at the repair site.

Clinical applications across five tendon and soft tissue indications

X-Repair is FDA 510(k) cleared for reinforcement of soft tissues repaired by suture or suture anchors, including reinforcement of rotator cuff, patellar, Achilles, biceps, and quadriceps tendons. The device is not intended to replace normal body structure or provide the full mechanical load-bearing function of the tendon. Its role is augmentation: supporting the repaired tissue while biologic healing establishes the structural integrity that the repair ultimately depends on.

X-Repair has been used in open, mini-open, and arthroscopic procedures. In open and mini-open approaches, the addition of X-Repair extends procedure time by approximately 10 to 15 minutes. Arthroscopic use requires additional technical expertise and adds approximately 20 to 30 minutes to the procedure. The majority of clinical cases performed with X-Repair have been done arthroscopically. The device is available in a range of sizes to accommodate variation in tear size and patient anatomy, addressing a large range of tendon and soft tissue defects requiring surgical repair.

What distinguishes X-Repair from alternative augmentation products

Most augmentation products used in tendon repair are allogeneic, derived from human cadavers, or xenogeneic, derived from animals. Both carry potential risks of infection and greater variability in product properties compared to a synthetic device manufactured under controlled conditions. X-Repair is fully synthetic, eliminating those risks while delivering mechanical properties that match native tendon more closely than existing alternatives.

X-Repair should not be cut during surgery, as it is a woven material. It is available in a broad range of sizes to meet the range of surgical needs without requiring intraoperative modification. Synthasome continues to develop new orthobiologics products with applications in tendon, ligament, and articular cartilage repair and regeneration, building on the tissue engineering and bioengineering foundation that produced X-Repair.

HS Fiber and HS Split Stitch: sutures designed for arthroscopic precision

Alongside X-Repair, Synthasome produces two sutures designed to support the demands of arthroscopic orthopedic surgery. HS Fiber is a non-absorbable braided suture made from fibers of ultra-high molecular weight long-chain linear polyethylene. The Core-loc design delivers high knot strength while the eBraid design provides superior handling characteristics. Four colours with a triaxial pattern give the suture outstanding visibility and distinguishing features that are particularly important for suture management in arthroscopic procedures.

HS Fiber is available in five catalogue configurations covering different colour combinations and needle options, with tensile strengths ranging from 42.8 to 78.1 lbf and knot pull strengths from 30.9 to 38.0 lbf. The HS Split Stitch uses HS Fiber with both ends returned to a half-circle taper needle, providing an additional configuration for surgeons who prefer this format in their repair technique.

To learn more about Synthasome products available through Synchrocare, visit www.synchrocare.com.

Every surgeon who has tried to introduce a new device into their institution has sat in that meeting. The value analysis committee. The supply chain director. The CMO. The question they always ask is some version of the same thing: show us why this is better than what we already use. Personal conviction is not enough in that room. Clinical data is.

The surgeons who move new devices through institutional adoption processes most effectively are the ones who understand not just that the evidence supports the device, but how to present that evidence in a way that addresses the specific concerns of each stakeholder. That is a skill worth developing deliberately.

Know your audience before the meeting

A supply chain director cares about cost per case, contract compatibility, and inventory implications. A CMO cares about outcome metrics, complication rates, and accreditation posture. A value analysis committee member cares about evidence quality, FDA clearance status, and how the device compares to the current standard of care.

The same published study can be presented differently to each of these audiences without misrepresenting the data. Leading with what matters most to the person across the table is not salesmanship. It is communication.

Use the evidence hierarchy correctly

Not all evidence carries equal weight in institutional adoption conversations. Randomised controlled trials, systematic reviews, and peer-reviewed outcome studies carry more weight than case series and manufacturer-funded white papers. Knowing where your device’s evidence sits in that hierarchy, and being transparent about it, builds more credibility than overstating a weaker data set.

Synchrocare provides peer-reviewed publications and clinical data for every product in its portfolio. Medical sales consultants are trained to help surgeons understand the evidence behind each device and prepare for the clinical questions that arise in adoption discussions.

Address the cost conversation directly

Total cost of ownership is almost always the subtext of an adoption conversation, even when it is not the stated concern. A device that reduces revision rates, shortens OR time, or decreases post-operative complications carries a financial argument alongside its clinical one. Building that argument with facility-specific data, using the facility’s own complication and revision benchmarks where available, makes it concrete rather than theoretical.

Your distributor is a resource in building that case. Synchrocare’s medical sales consultants support surgeons through the adoption process with clinical resources, outcome data, and the kind of facility-specific context that makes a value analysis presentation land.

Follow through after approval

Getting a device approved is the start of the adoption process, not the end of it. The clinical team still needs training. The instrument sets need to be managed. The first few cases need close support. A distributor who disappears after approval and returns only for reorders is not an adoption partner.

Synchrocare treats clinical support as a continuous responsibility across every product in its portfolio. That continuity is what turns an approved device into an embedded one.

To learn more about Synchrocare’s clinical support and adoption resources, visit www.synchrocare.com.

The pre-operative briefing had been running for four minutes when the scrub tech asked about the insertion sequence for the new fixation system. The surgeon answered. The circulating nurse made a note. The case started on time and ran without hesitation. That four-minute conversation prevented the kind of mid-case pause that costs twice as long and carries ten times the cognitive load.

Team-based pre-operative preparation is one of the most underused performance tools in surgical practice. Not because surgeons do not value it, but because the structure for making it consistent and productive is rarely built into the workflow. When it is, the difference shows up in case flow, team confidence, and the quality of intraoperative decisions.

What effective pre-case preparation covers

A productive pre-operative briefing is not a full device in-service. It is a focused, time-efficient alignment around the specific case at hand. It covers the device or implant being used, the insertion or application sequence, the anatomical considerations relevant to this patient, and any aspects of the procedure where the team’s response needs to be synchronised.

For cases involving devices that are new to the team or used less frequently, that briefing also surfaces knowledge gaps before the case rather than during it. A scrub tech who asks a question in the briefing room contributes to the case. The same question asked at the instrument table creates friction.

The role of shared device knowledge

Intraoperative hesitation is almost never about skill. It is about uncertainty. A team that has collectively reviewed the device, the sequence, and the expected intraoperative milestones operates with a shared mental model that reduces the cognitive load on every member, including the surgeon.

Synchrocare’s medical sales consultants are trained to support pre-operative preparation as part of their clinical role, not just the initial in-service. That includes being available for pre-case reviews, providing technique guides and procedure summaries that teams can use in briefings, and answering device-specific questions before the patient is on the table.

Building the habit across your team

The facilities where team-based preparation is most consistent are the ones that have made it structural rather than optional. A five-minute standing briefing before the first case of a new device, a shared procedure summary posted in the scrub room, and a pre-case checklist that includes device-specific items. These are small investments that compound over time.

For surgical services directors and lead surgeons building high-performance teams, pre-operative device preparation is as important as any other component of surgical competency. The training that happens before the case determines how much thinking the team has to do during it.

To learn more about Synchrocare’s clinical support and pre-operative resources, visit www.synchrocare.com.

Scaling national distribution for a medical device is one of the most capital-intensive challenges a manufacturer faces after FDA clearance. Hiring, training, credentialing, and managing a direct sales force across multiple states requires headcount, overhead, and time that most companies cannot absorb at the pace the market demands. The alternative, a distribution partner with an established national network, addresses that challenge, but only if the network is built on the right foundations.

Synchrocare’s franchise model is designed specifically to create exactly this kind of network. Each franchise owner is a trained, compliant, market-ready representative operating within an established distribution infrastructure. For manufacturers evaluating national expansion, understanding what that model delivers is the starting point for evaluating whether Synchrocare is the right partner.

Each franchise owner is a credentialed market entry point

A Synchrocare franchise owner enters their market having completed a comprehensive training program covering product knowledge, procedure-relevant anatomy, surgical technique considerations, and the full compliance framework, including the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act. Every owner undergoes a thorough background check and maintains industry-standard insurance before entering any facility.

For a manufacturer adding their product to Synchrocare’s portfolio, each franchise territory represents immediate access to a trained, credentialed representative who is already known to local hospitals, ambulatory surgery centers, and surgeons. The groundwork of clinical relationship-building and facility credentialing has been laid before your product arrives in the territory. That compression of the market entry timeline is one of the most concrete advantages of the network model for manufacturers.

Clinical depth that protects your product’s reputation in the field

National distribution that lacks clinical depth creates its own risks for manufacturers. A representative who cannot speak credibly about the anatomy, the surgical technique, and the clinical rationale behind a device does not just underperform. They actively damage the surgeon’s confidence in the product. One poor clinical interaction early in a territory can set adoption back by months.

Synchrocare’s training model addresses this by ensuring that every franchise owner understands not just how to use a product but why it is designed the way it is and what clinical problems it is engineered to solve. That depth is what earns standing in the OR and what sustains surgeon relationships through the learning curve of a new device introduction.

Compliance infrastructure that protects you

A distributor’s compliance failures do not stay with the distributor. Violations of the Stark Law, the Anti-Kickback Statute, or the False Claims Act create liability that travels back to the manufacturer whose products were involved. Every Synchrocare franchise owner operates within Synchrocare’s compliance framework, with documented training, background checks, and insurance as non-negotiable standards across the entire network.

For manufacturers who have invested years in building a product and a clinical reputation, that compliance foundation is not a courtesy. It is a structural protection for everything you have built.

To learn more about partnering with Synchrocare as your national distribution partner, visit www.synchrocare.com.

Most people evaluating a medical device franchise spend the majority of their time on two questions: how much does it cost, and how much can I earn – both matter. Neither one tells you whether the franchise model you are looking at will actually give you what you need to build a sustainable, growing business. The questions that determine that are rarely the first ones asked.

Before you sign anything, here is the framework worth applying to any medical device franchise opportunity, including this one.

Start with the product portfolio

A franchise is only as strong as the products it gives you access to. Evaluate the portfolio the same way you would evaluate any device before using it clinically: what clinical problems does it address, how strong is the evidence behind it, what is the FDA clearance status of each product, and does the portfolio serve multiple surgical specialties or depend heavily on a single indication?

Synchrocare’s portfolio spans twelve manufacturer partners covering orthopedic fixation, spine and extremity surgery, advanced wound care, orthobiologics, regenerative medicine, and bone grafting. That breadth means franchise owners are not dependent on a single clinical trend or a single surgical relationship. It also means you enter facilities as a resource across multiple service lines, which deepens your value to the hospitals and ASCs you work with.

Evaluate the training program before you trust the territory

The quality of the training program determines the quality of the franchise owner that comes out of it. Ask specifically what the program covers: product knowledge only, or also anatomy, surgical technique, and compliance? How long does it run? What is the assessment process? Is there ongoing education after initial training or a single in-service, and then you are on your own?

Synchrocare’s medical sales consultant training program covers product knowledge, the steps in the sales process from start to finish, procedure-relevant anatomy, surgical technique considerations, and the full compliance framework, including the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act. Background checks and insurance requirements apply across the network. Every franchise owner completes that program before entering any facility.

Understand the compliance infrastructure

Compliance in medical device sales is not a background consideration. It governs how you enter facilities, how you engage with surgeons, how you run sales activities, and how you document everything. A franchise model with a weak compliance infrastructure exposes you personally and professionally.

Ask any franchise you evaluate: what compliance training is provided, how it is updated as regulations change, and what happens when a compliance question arises in the field. The answer tells you a great deal about how seriously the franchisor takes the regulatory environment you will be operating in.

Clarify what ownership actually means

Not all franchise agreements treat ownership the same way. Some give you a territory in name but retain the right to reassign or restructure it. Some tie your equity to performance metrics you do not control. Read the agreement carefully and understand specifically what you own, what you can sell, and under what conditions the relationship can be restructured.

The Synchrocare franchise model is built on the premise that the work of building a territory should belong to the person who did it. Before you commit to any franchise, make sure you understand exactly what that commitment creates and what you walk away with if you ever choose to exit. Is the opportunity you are evaluating built on that same premise?

To learn more about the Synchrocare franchise opportunity, visit www.synchrocare.com/franchising.

Five years from now, the medical sales professionals who made the most of this decade will not only be the ones who hit the highest commission numbers, they will be the ones who built something. A territory with depth. Surgeon relationships with genuine loyalty. A business with real equity and a growth trajectory they control.

Building that kind of territory requires more than clinical knowledge and sales skill, though both matter. It requires a deliberate approach to territory development from the first day of market entry, and it requires the structural support to execute that approach consistently over time. That is what the Synchrocare franchise model provides.

Territory planning starts before the first call

The most productive territories in medical device sales are not built by making the most calls. They are built by making the right calls in the right sequence. Before your first day in the market, Synchrocare’s training program gives you a clear picture of the product portfolio, the clinical indications that drive demand, and the facility types and surgical specialties where each product has the strongest fit.

That preparation lets you enter your territory with a prioritization framework rather than a contact list. You know which facilities have the highest concentration of relevant surgical volume, which specialties your portfolio serves most directly, and which surgeon profiles are most likely to engage early. That focus in the first six months determines the trajectory of the next five years.

Depth before breadth in relationship development

New franchise owners sometimes feel pressure to cover as much ground as possible, as quickly as possible. The territories that build the strongest long-term value do the opposite. They go deep in a manageable number of facilities before expanding outward. A surgeon who trusts you completely in one hospital is worth more to your territory than five surgeons who know your name in five different ones.

Depth comes from consistent presence, clinical preparedness, and the kind of follow-through that makes a surgeon confident their patients are well supported after every case. Synchrocare’s back-office infrastructure, customer service support, and ongoing clinical resources give franchise owners the operational backing to deliver that level of follow-through without it consuming all their capacity.

Building equity that compounds

Every strong surgeon relationship a Synchrocare franchise owner builds accrues to their business. Every facility where their compliance record is clean and their clinical support is consistent adds to the value of the territory they are developing. Unlike a traditional sales role where that value belongs to an employer, a franchise owner’s equity compounds in their own name.

The Synchrocare franchise model is built on the premise that the people who do the work of building a territory should own what they build. The network provides the portfolio, the infrastructure, the training, and the purchasing power. The franchise owner provides the clinical credibility and the relationship depth that no infrastructure can substitute.

In five years, which side of that equation do you want to be on?

To learn more about the Synchrocare franchise opportunity, visit www.synchrocare.com/franchising.

Two surgeons. Same training program. Same patient population. Meaningfully different long-term outcomes. The difference, more often than clinical data suggests, is not technical skill. It is how deliberately each one evaluates and selects the devices they use.

Device selection in surgical practice is rarely treated as a formal discipline. It happens through exposure, through rep relationships, through what is available on contract at a given facility. The surgeons who produce the most consistent outcomes over time approach it differently. They ask different questions before a device earns a place in their practice.

Start with an indication fit

Every device has an indication profile. The surgeons who use devices well match that profile precisely to their patient before the case, not during it. A device that performs excellently within its indicated use performs unpredictably outside it.

Reviewing indication criteria against your patient’s specific anatomy, pathology, and risk profile before selecting a device is the first discipline. It is also the one most frequently compressed under scheduling pressure.

Read the clinical evidence yourself.

Published clinical evidence on a device tells you more than a rep presentation. It tells you which patient populations were studied, what the follow-up period was, what the comparator was, and where the variance in outcomes appeared. Those details determine whether the data applies to your patients.

Synchrocare provides peer-reviewed publications and clinical data for every product in its portfolio. The expectation is not that surgeons will accept the data uncritically. It is that they will engage with it and use it to make better-informed decisions for individual patients.

Evaluating technique demands honestly

Some devices have a steeper learning curve than their IFU suggests. The honest evaluation of a device includes an honest evaluation of where you are on that curve and what support you need to use it at the level the clinical evidence assumes.

Synchrocare’s medical sales consultants are trained to support surgeons through the learning curve on new devices with ongoing case support, technique guidance, and access to clinical resources beyond the initial in-service. That support is built into every product partnership, not offered as an optional add-on.

Track your own outcomes

The surgeons with the clearest picture of which devices serve their patients best are the ones tracking their own outcomes systematically. Complication rates, revision rates, patient-reported function scores, and return to activity timelines tell you things that published studies cannot, because they reflect your specific patient population and your specific technique.

Building that data discipline into your practice takes time. It returns compounding value across a career.

To learn more about Synchrocare’s clinical support resources and product portfolio, visit www.synchrocare.com.

$50,000+

The estimated average cost of a single preventable surgical complication, including additional care, extended stay, and administrative burden. Source: AHRQ data.

Purchase price is the number procurement teams see most clearly. It appears on every vendor proposal, drives most contract negotiations, and is the easiest variable to compare across competing distributors. It is also the smallest part of what a medical device relationship actually costs a facility over time.

The administrators who manage device relationships most effectively think in total cost of ownership. They account for the variables that do not appear on a purchase order but show up in complication rates, staff training hours, OR delays, and compliance incidents. Understanding that the full picture is what turns a procurement decision into a strategic one.

The cost of inadequate clinical support after the sale

When a device enters a facility without adequate clinical support, the cost of that gap falls on the facility. Clinical educators spend hours filling in training gaps that a distributor’s in-service should have covered. Circulating nurses field questions; they should not need to ask. Surgeons work around knowledge gaps in their teams that slow procedure times and increase cognitive load.

Synchrocare’s medical sales consultants provide comprehensive in-service training, ongoing technique support, and access to technique guides, case studies, and clinical FAQs across every product in the portfolio. That continuity of support reduces the internal resource burden on facilities and keeps teams competent on devices long after the initial product introduction.

The cost of compliance exposure from under-qualified representatives

A distributor representative who enters your facility without proper credentialing, adequate insurance, or training on the regulatory standards governing their conduct creates institutional exposure. A single compliance incident, a Stark Law violation, an Anti-Kickback Statute issue, or a breach of the AdvaMed Code of Ethics does not stay with the distributor. It travels to the facility.

Every Synchrocare medical sales consultant undergoes a thorough background check, maintains industry-standard insurance, and completes training on every applicable compliance standard before entering any facility. All activities are conducted in full compliance with applicable regulations and industry standards. For compliance officers who manage vendor credentialing, that documented foundation reduces both risk and administrative overhead.

The cost of supply chain gaps in high-volume surgical schedules

OR scheduling depends on the reliable availability of the instruments and implants that those cases require. A distributor whose order management and customer service infrastructure cannot sustain that reliability creates a cost that is felt directly in the OR. Cases get rescheduled. Staff time is consumed managing exceptions. Surgeons lose confidence in products they associate with supply problems rather than clinical performance.

Synchrocare provides back-office and customer service support specifically designed to keep supply chains reliable for the hospitals and ambulatory surgery centers it serves. For administrators managing high-volume surgical schedules, operational reliability is not a secondary consideration. It is a direct contributor to OR efficiency and revenue consistency.

To learn more about how Synchrocare supports hospital and ASC operations, visit www.synchrocare.com.